Hae-Dong Jang PhD, MD , Jae Chul Lee MD, PhD , Byung-Joon Shin PhD
{"title":"第29页。采用“外侧通道”进行L5-S1段微创斜腰椎体间融合术的新手术入路:临床系列和技术说明","authors":"Hae-Dong Jang PhD, MD , Jae Chul Lee MD, PhD , Byung-Joon Shin PhD","doi":"10.1016/j.xnsj.2025.100653","DOIUrl":null,"url":null,"abstract":"<div><h3>BACKGROUND CONTEXT</h3><div>There are various approach techniques for the interbody fusion of the lumbosacral region (L5-S1), and each method has its own advantages, disadvantages, and clinical features. The minimally invasive oblique lumbar interbody fusion (MI-OLIF) L5-S1 was introduced to overcome the limitations of conventional fusion techniques, however, MI-OLIF is not possible using the standard method due to vascular structures in some cases.</div></div><div><h3>PURPOSE</h3><div>To introduce the “lateral corridor” as an optional surgical approach for MI-OLIF L5-S1 and report the details of the surgical technique with a clinical case series.</div></div><div><h3>STUDY DESIGN/SETTING</h3><div>A clinical series and technical note.</div></div><div><h3>PATIENT SAMPLE</h3><div>Patients who underwent MI-OLIF L5-S1 at our hospital between July 2015 and October 2022 for degenerative lumbar disease were included. Patients with confirmed spinal surgery history within 1 year and those with an infection, tumor, or trauma were excluded. Among the 107 patients who underwent MI-OLIF L5-S1, 26 patients (24.3%) who received the “lateral corridor” technique were included.</div></div><div><h3>OUTCOME MEASURES</h3><div>The type and frequency of branch vessels that required additional manipulations were reviewed, and the frequency of intraoperative vascular injury was investigated.</div></div><div><h3>METHODS</h3><div>We propose a novel surgical approach using the “lateral corridor” to access the lateral window to the left common iliac vein (LCIV) in this study as an alternative to the standard technique using the central corridor. The LCIV is manipulated in significantly different ways between the two approaches. The central corridor method uses the medial window of the LCIV and retracts the LCIV and the left common iliac artery laterally. In contrast, the “lateral corridor” method uses the lateral window of the LCIV and retracts all vasculature medially. It is the space between the lateral margin of the LCIV and the medial margin of the left psoas muscle.</div></div><div><h3>RESULTS</h3><div>We introduced surgical technique using the \"lateral corridor\" in the following steps: 1) patient position, localization, and skin incision, 2) soft tissue dissection, 3) vascular dissection, 4) intervertebral disc and endplate preparation, 5) cage insertion and orientation, and 6) closure and posterior procedure. Branch vessel ligation was required in 42.3% of the patients. The types of branch vessels that required ligation were seven cases (26.9%) of the iliolumbar vein (ILV) and six cases (23.1%) of the ascending lumbar vein (ALV). The ILV and ALV were ligated in two cases. None of the patients developed intraoperative vascular injuries.</div></div><div><h3>CONCLUSIONS</h3><div>We introduced the \"lateral corridor\" as an alternative approach for MI-OLIF L5-S1, implemented it in 24.3% of the patient cohort, and reported favorable outcomes devoid of vascular complications. The “lateral corridor” necessitated ligation of the ILV or ALV in 42.3% of cases. The “lateral corridor” approach appears to be a promising surgical technique, offering feasibility even in instances where the vascular anatomy precludes the employment of the conventional approach.</div></div><div><h3>FDA Device/Drug Status</h3><div>This abstract does not discuss or include any applicable devices or drugs.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"22 ","pages":"Article 100653"},"PeriodicalIF":2.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P29. A novel surgical approach using the “lateral corridor” for minimally invasive oblique lumbar interbody fusion at L5-S1: a clinical series and technical note\",\"authors\":\"Hae-Dong Jang PhD, MD , Jae Chul Lee MD, PhD , Byung-Joon Shin PhD\",\"doi\":\"10.1016/j.xnsj.2025.100653\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>BACKGROUND CONTEXT</h3><div>There are various approach techniques for the interbody fusion of the lumbosacral region (L5-S1), and each method has its own advantages, disadvantages, and clinical features. The minimally invasive oblique lumbar interbody fusion (MI-OLIF) L5-S1 was introduced to overcome the limitations of conventional fusion techniques, however, MI-OLIF is not possible using the standard method due to vascular structures in some cases.</div></div><div><h3>PURPOSE</h3><div>To introduce the “lateral corridor” as an optional surgical approach for MI-OLIF L5-S1 and report the details of the surgical technique with a clinical case series.</div></div><div><h3>STUDY DESIGN/SETTING</h3><div>A clinical series and technical note.</div></div><div><h3>PATIENT SAMPLE</h3><div>Patients who underwent MI-OLIF L5-S1 at our hospital between July 2015 and October 2022 for degenerative lumbar disease were included. Patients with confirmed spinal surgery history within 1 year and those with an infection, tumor, or trauma were excluded. Among the 107 patients who underwent MI-OLIF L5-S1, 26 patients (24.3%) who received the “lateral corridor” technique were included.</div></div><div><h3>OUTCOME MEASURES</h3><div>The type and frequency of branch vessels that required additional manipulations were reviewed, and the frequency of intraoperative vascular injury was investigated.</div></div><div><h3>METHODS</h3><div>We propose a novel surgical approach using the “lateral corridor” to access the lateral window to the left common iliac vein (LCIV) in this study as an alternative to the standard technique using the central corridor. The LCIV is manipulated in significantly different ways between the two approaches. The central corridor method uses the medial window of the LCIV and retracts the LCIV and the left common iliac artery laterally. In contrast, the “lateral corridor” method uses the lateral window of the LCIV and retracts all vasculature medially. It is the space between the lateral margin of the LCIV and the medial margin of the left psoas muscle.</div></div><div><h3>RESULTS</h3><div>We introduced surgical technique using the \\\"lateral corridor\\\" in the following steps: 1) patient position, localization, and skin incision, 2) soft tissue dissection, 3) vascular dissection, 4) intervertebral disc and endplate preparation, 5) cage insertion and orientation, and 6) closure and posterior procedure. Branch vessel ligation was required in 42.3% of the patients. The types of branch vessels that required ligation were seven cases (26.9%) of the iliolumbar vein (ILV) and six cases (23.1%) of the ascending lumbar vein (ALV). The ILV and ALV were ligated in two cases. None of the patients developed intraoperative vascular injuries.</div></div><div><h3>CONCLUSIONS</h3><div>We introduced the \\\"lateral corridor\\\" as an alternative approach for MI-OLIF L5-S1, implemented it in 24.3% of the patient cohort, and reported favorable outcomes devoid of vascular complications. The “lateral corridor” necessitated ligation of the ILV or ALV in 42.3% of cases. The “lateral corridor” approach appears to be a promising surgical technique, offering feasibility even in instances where the vascular anatomy precludes the employment of the conventional approach.</div></div><div><h3>FDA Device/Drug Status</h3><div>This abstract does not discuss or include any applicable devices or drugs.</div></div>\",\"PeriodicalId\":34622,\"journal\":{\"name\":\"North American Spine Society Journal\",\"volume\":\"22 \",\"pages\":\"Article 100653\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"North American Spine Society Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666548425000733\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"North American Spine Society Journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666548425000733","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
P29. A novel surgical approach using the “lateral corridor” for minimally invasive oblique lumbar interbody fusion at L5-S1: a clinical series and technical note
BACKGROUND CONTEXT
There are various approach techniques for the interbody fusion of the lumbosacral region (L5-S1), and each method has its own advantages, disadvantages, and clinical features. The minimally invasive oblique lumbar interbody fusion (MI-OLIF) L5-S1 was introduced to overcome the limitations of conventional fusion techniques, however, MI-OLIF is not possible using the standard method due to vascular structures in some cases.
PURPOSE
To introduce the “lateral corridor” as an optional surgical approach for MI-OLIF L5-S1 and report the details of the surgical technique with a clinical case series.
STUDY DESIGN/SETTING
A clinical series and technical note.
PATIENT SAMPLE
Patients who underwent MI-OLIF L5-S1 at our hospital between July 2015 and October 2022 for degenerative lumbar disease were included. Patients with confirmed spinal surgery history within 1 year and those with an infection, tumor, or trauma were excluded. Among the 107 patients who underwent MI-OLIF L5-S1, 26 patients (24.3%) who received the “lateral corridor” technique were included.
OUTCOME MEASURES
The type and frequency of branch vessels that required additional manipulations were reviewed, and the frequency of intraoperative vascular injury was investigated.
METHODS
We propose a novel surgical approach using the “lateral corridor” to access the lateral window to the left common iliac vein (LCIV) in this study as an alternative to the standard technique using the central corridor. The LCIV is manipulated in significantly different ways between the two approaches. The central corridor method uses the medial window of the LCIV and retracts the LCIV and the left common iliac artery laterally. In contrast, the “lateral corridor” method uses the lateral window of the LCIV and retracts all vasculature medially. It is the space between the lateral margin of the LCIV and the medial margin of the left psoas muscle.
RESULTS
We introduced surgical technique using the "lateral corridor" in the following steps: 1) patient position, localization, and skin incision, 2) soft tissue dissection, 3) vascular dissection, 4) intervertebral disc and endplate preparation, 5) cage insertion and orientation, and 6) closure and posterior procedure. Branch vessel ligation was required in 42.3% of the patients. The types of branch vessels that required ligation were seven cases (26.9%) of the iliolumbar vein (ILV) and six cases (23.1%) of the ascending lumbar vein (ALV). The ILV and ALV were ligated in two cases. None of the patients developed intraoperative vascular injuries.
CONCLUSIONS
We introduced the "lateral corridor" as an alternative approach for MI-OLIF L5-S1, implemented it in 24.3% of the patient cohort, and reported favorable outcomes devoid of vascular complications. The “lateral corridor” necessitated ligation of the ILV or ALV in 42.3% of cases. The “lateral corridor” approach appears to be a promising surgical technique, offering feasibility even in instances where the vascular anatomy precludes the employment of the conventional approach.
FDA Device/Drug Status
This abstract does not discuss or include any applicable devices or drugs.